Showing 101 - 120 results of 2,284 for search '"Cardiovascular disease"', query time: 0.05s Refine Results
  1. 101

    Characteristics of the Relationship of Kidney Dysfunction with Cardiovascular Disease in High Risk Patients with Diabetes by Attilio Losito, Loretta Pittavini, Ivano Zampi, Elena Zampi

    Published 2016-01-01
    “…We aimed at comparing the relationship of reduced estimated glomerular filtration rate (eGFR) with cardiovascular disease (CVD) and mortality between high risk patients with and without type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  2. 102
  3. 103

    Family history of cardiovascular disease and death in patients with out-of-hospital cardiac arrest by Magnus Gylling, Johanna Krøll, Peder Emil Warming, Carolina Malta Hansen, Fredrik Folke, Steen M. Hansen, Lars Køber, Christian Torp-Pedersen, Rodrigue Garcia, Jacob Tfelt-Hansen, Peter E. Weeke

    Published 2025-03-01
    “…Aim: How a family history of cardiovascular disease (CVD) or death influences the risk of out-of-hospital cardiac arrest (OHCA) is unknown. …”
    Get full text
    Article
  4. 104

    Health literacy and cardiovascular disease prevention: a systematic scoping review protocol by Vanessa Vaughan, Mojtaba Lotfaliany, Bonnie Beasant, Georgie Lee, Sarah Hosking

    Published 2022-06-01
    “…Literature investigating cardiovascular disease (CVD) prevention and health literacy often exist in silos, only exploring one element of prevention. …”
    Get full text
    Article
  5. 105
  6. 106

    Topological Indices of Novel Drugs Used in Cardiovascular Disease Treatment and Its QSPR Modeling by Fozia Bashir Farooq, Nadeem Ul Hassan Awan, Saima Parveen, Nazeran Idrees, Salma Kanwal, Tarig A. Abdelhaleem

    Published 2022-01-01
    “…., and other drugs employed to treat cardiovascular disease are studied and the QSPR analysis goal will probe the mathematical relationship of properties such as (polarity, boiling point, enthalpy, etc.) and assorted descriptors associated to drug’s structure. …”
    Get full text
    Article
  7. 107

    The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases by Xueyan Zhang, Yihan Yu, Hanyu Lei, Yufeng Cai, Jie Shen, Ping Zhu, Qingnan He, Mingyi Zhao

    Published 2020-01-01
    “…Cardiovascular disease, which can lead to angina and shortness of breath, remains one of the most serious threats to human health. …”
    Get full text
    Article
  8. 108

    Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease by Joy Dip Barua, Shudeb Babu Sen Omit, Humayan Kabir Rana, Nitun Kumar Podder, Utpala Nanda Chowdhury, Md Habibur Rahman

    Published 2022-01-01
    “…Background. Cardiovascular disease (CVD) is the combination of coronary heart disease, myocardial infarction, rheumatic heart disease, and peripheral vascular disease of the heart and blood vessels. …”
    Get full text
    Article
  9. 109
  10. 110

    Lipid Metabolism and its Relationship with Cardiovascular Diseases from a Biochemical and Genetic Approach by Myriam Lizeth Morales Pilataxi, Angélica Victoria Herrera Martínez, Diego Eduardo Guato Canchinia, Cristian Javier Calle Cárdenas

    Published 2024-08-01
    “…Cardiovascular diseases are a global health concern, and are one of the main causes of morbidity and mortality worldwide. …”
    Get full text
    Article
  11. 111

    Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease by Kosaku Nitta

    Published 2011-01-01
    “…Although individual components of MetS have been implicated in the development of chronic kidney disease (CKD), few studies have examined the effect of combinations of the components of MetS on the development of CKD and cardiovascular disease (CVD). The prevalence of MetS is increasing worldwide in both developing and developed countries, and early detection and treatment of MetS would be a cost-effective strategy for preventing the development of CKD. …”
    Get full text
    Article
  12. 112
  13. 113

    Prevalence of Cardiovascular Disease Risk Factors in the Women Population Covered by Health Centers in Ardabil by Leli Avesta, Sina Rasoolzadeh, Mahdi Naeim, Aziz Kamran

    Published 2022-01-01
    “…Abdominal obesity (waist above 88), obesity and overweight (high body mass index), high triglycerides, high cholesterol, and LDL and HDL outside the proper range were the most important and risk factors for cardiovascular disease among women.…”
    Get full text
    Article
  14. 114
  15. 115

    Impact of Visit-to-Visit Triglyceride-Glucose Index Variability on the Risk of Cardiovascular Disease in the Elderly by Fei Chen, Ying Pan, Ziqing Liu, Rong Huang, Jing Wang, Jian Shao, Yaqin Gong, Xiyi Sun, Xiaobo Jiang, Weihao Wang, Zhaoqiang Li, Shao Zhong, Qi Pan, Kaixin Zhou

    Published 2022-01-01
    “…The aging population is increasingly susceptible to cardiovascular disease (CVD). Visit-to-visit variability in glucose and lipid levels both contributed to CVD risk independent of their mean values. …”
    Get full text
    Article
  16. 116
  17. 117

    Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease by Xiao-Lan Zhao, Zhang-Jing Cao, Ke-Di Li, Fei Tang, Li-Yue Xu, Jing-Nan Zhang, Dong Liu, Cheng Peng, Hui Ao, Hui Ao

    Published 2025-01-01
    “…Atherosclerotic cardiovascular disease (ASCVD) causes significant morbidity and mortality globally. …”
    Get full text
    Article
  18. 118
  19. 119
  20. 120

    Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease by Zhen Li, Min Gu, Aline Zaparte, Xiaoming Fu, Kala Mahen, Marko Mrdjen, Xinmin S. Li, Zhihong Yang, Jing Ma, Themis Thoudam, Kristina Chandler, Maggie Hesler, Laura Heathers, Kiersten Gorse, Thanh Trung Van, David Wong, Aaron M. Gibson, Zeneng Wang, Christopher M. Taylor, Pearl Quijada, Catherine A. Makarewich, Stanley L. Hazen, Suthat Liangpunsakul, J. Mark Brown, David J. Lefer, David A. Welsh, Thomas E. Sharp

    Published 2024-12-01
    “…Abstract The mechanism(s) underlying gut microbial metabolite (GMM) contribution towards alcohol-mediated cardiovascular disease (CVD) is unknown. Herein we observe elevation in circulating phenylacetylglutamine (PAGln), a known CVD-associated GMM, in individuals living with alcohol use disorder. …”
    Get full text
    Article